Brainsway (BWAY)
(Delayed Data from NSDQ)
$5.33 USD
-0.12 (-2.20%)
Updated May 10, 2024 04:00 PM ET
After-Market: $5.34 +0.01 (0.19%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$5.33 USD
-0.12 (-2.20%)
Updated May 10, 2024 04:00 PM ET
After-Market: $5.34 +0.01 (0.19%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Zacks News
After Plunging -13.63% in 4 Weeks, Here's Why the Trend Might Reverse for Brainsway (BWAY)
by Zacks Equity Research
Brainsway (BWAY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
All You Need to Know About Brainsway Ltd. Sponsored ADR (BWAY) Rating Upgrade to Buy
by Zacks Equity Research
Brainsway Ltd. Sponsored ADR (BWAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stocks to Buy for March 11th
by Zacks Equity Research
BWAY, WILYY and CRH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 11, 2024.
New Strong Buy Stocks for March 11th
by Zacks Equity Research
BWAY, WILLY, IDCC, BRKL and SBSI have been added to the Zacks Rank #1 (Strong Buy) List on March 11, 2024.
What's in the Offing for Brainsway (BWAY) in Q4 Earnings?
by Zacks Equity Research
Brainsway's (BWAY) fourth-quarter 2023 performance is likely to have been impacted by the strong momentum across the entire business.
Zacks.com featured highlights VirTra, Universal Stainless & Alloy, Carrols Restaurant, BrainsWay and Virco
by Zacks Equity Research
VirTra, Universal Stainless & Alloy, Carrols Restaurant, BrainsWay and Virco have been highlighted in this Screen of The Week article.
5 Stocks With Recent Price Strength in a Volatile Market
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are VTSI, USAP, TAST, BWAY, VIRC.
3 Top-Ranked Small-Caps Delivering Large Gains
by Derek Lewis
Small-caps have found plenty of buyers over the last few months, undoubtedly a welcomed development as investors look to find strength outside of large-caps.
Recent Price Trend in Brainsway Ltd. Sponsored ADR (BWAY) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway Ltd. Sponsored ADR (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Best Momentum Stocks to Buy for January 2nd
by Zacks Equity Research
BWAY, RYAAY and EQX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 2, 2024.
New Strong Buy Stocks for January 2nd
by Zacks Equity Research
GPRE, FFIC, NGD, BWAY and EQX have been added to the Zacks Rank #1 (Strong Buy) List on January 2, 2024.
Does Brainsway Ltd. Sponsored ADR (BWAY) Have the Potential to Rally 48.15% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 48.2% upside potential for Brainsway Ltd. Sponsored ADR (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
by Zacks Equity Research
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
Brainsway Ltd. Sponsored ADR (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Brainsway Ltd. Sponsored ADR (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Wall Street Analysts Predict a 68.72% Upside in Brainsway Ltd. Sponsored ADR (BWAY): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Brainsway Ltd. Sponsored ADR (BWAY) points to a 68.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BrainsWay (BWAY) Strengthens South Korean Foothold With Deep TMS
by Zacks Equity Research
BrainsWay's (BWAY) Deep TMS targets affected brain structures with a magnetic field, stimulating crucial neural networks.
New Strong Buy Stocks for December 1st
by Zacks Equity Research
AQST, TM, LEU, BWAY and MOD have been added to the Zacks Rank #1 (Strong Buy) List on December 1, 2023.
Brainsway Ltd. Sponsored ADR (BWAY) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Brainsway Ltd. Sponsored ADR (BWAY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Momentum in Brainsway Ltd. Sponsored ADR (BWAY) Should Keep going
by Zacks Equity Research
Brainsway Ltd. Sponsored ADR (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
5 Solid Relative Price Strength Opportunities for Investors
by Nilanjan Choudhury
CLBT, BWAY, TAST, RCL and GIC are five stocks with explosive relative price strength.
How Much Upside is Left in Brainsway Ltd. Sponsored ADR (BWAY)? Wall Street Analysts Think 50.27%
by Zacks Equity Research
The consensus price target hints at a 50.3% upside potential for Brainsway Ltd. Sponsored ADR (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Best Momentum Stocks to Buy for November 22nd
by Zacks Equity Research
BWAY, RIGL and BROS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 22, 2023.
New Strong Buy Stocks for November 22nd
by Zacks Equity Research
RIGL, BWAY, AVDX, IMGN and EAT have been added to the Zacks Rank #1 (Strong Buy) List on November 22, 2023.
Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how AC Immune (ACIU) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.
Has AVROBIO (AVRO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how AVROBIO, Inc. (AVRO) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.